Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.96 USD | +6.60% | +2.28% | +25.40% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.40% | 1.69B | |
+14.19% | 118B | |
+13.49% | 106B | |
-2.45% | 24.28B | |
+0.67% | 21.96B | |
-9.00% | 18.16B | |
-42.12% | 16.37B | |
-17.41% | 15.56B | |
+5.40% | 13.63B | |
+30.94% | 12.27B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics : Jefferies Adjusts Keros Therapeutics PT to $75 From $70, Maintains Buy Rating